INDICATIONS AND USAGE
Jakafi is a kinase inhibitor indicated for treatment of:
Please click here for Full Prescribing Information for Jakafi.
DOSAGE AND ADMINISTRATION
Doses should be individualized based on safety and efficacy. Starting doses per indication are noted below.
Acute Graft-Versus-Host Disease
Chronic Graft-Versus-Host Disease
Please click here for Full Prescribing Information for Jakafi.
DOSAGE FORMS AND STRENGTHS
Tablets: 5 mg, 10 mg, 15 mg, 20 mg and 25 mg.
Please click here for Full Prescribing Information for Jakafi.
WARNINGS AND PRECAUTIONS
Please click here for Full Prescribing Information for Jakafi.
ADVERSE REACTIONS
To report SUSPECTED ADVERSE REACTIONS, contact Incyte Corporation at 1-855-463-3463 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please click here for Full Prescribing Information for Jakafi.
DRUG INTERACTIONS
Please click here for Full Prescribing Information for Jakafi.
USE IN SPECIFIC POPULATIONS
Please click here for Full Prescribing Information for Jakafi.
Jakafi and the Jakafi logo are registered trademarks of Incyte.
Incyte and the Incyte logo are registered trademarks of Incyte.
All other trademarks are property of their respective owners.
© 2024, Incyte. MAT-JAK-05311 12/24
INDICATIONS AND USAGE
Jakafi is a kinase inhibitor indicated for treatment of:
IMPORTANT SAFETY INFORMATION
Please click here for Full Prescribing Information for Jakafi.